Women’s immune systems age more broadly than men’s
Same species, same lifespan pressures — but the immune system ages in strikingly different ways depending on whether you’re female or male.
A large new study published in Nature Aging profiled the immune cells of nearly 1,000 people across the full adult lifespan using single-cell transcriptomics — a technique that reads which genes are active in each individual cell at any given moment, like eavesdropping on thousands of conversations happening simultaneously inside the body.
The researchers found that women undergo more widespread age-related immune remodeling than men. This includes elevated signs of inflammaging — the chronic, low-grade background inflammation that quietly accumulates with age and is linked to a wide range of age-related diseases, from cardiovascular disease to neurodegeneration. Women also showed more transcriptional patterns associated with autoimmune conditions, diseases in which the immune system mistakenly attacks the body’s own tissues.
A broader shift, but not a better one
It has long been known that women make up around 80 percent of autoimmune disease cases. What remained unclear was how this connects to the biology of aging itself. This study suggests that the more extensive immunological remodeling seen in women — the large-scale shift in immune cell composition and function that occurs over decades — may help explain that disparity.
The team behind the research argues that these findings have direct implications for medicine. Drugs, vaccines, and longevity interventions are routinely tested and dosed without accounting for sex-specific differences in immune aging. If the underlying biology diverges this significantly, that’s a meaningful blind spot.
Mapping the aging immune system, cell by cell
Immunosenescence — the gradual decline in immune function that comes with age — has been a focus of longevity research for years. But most prior work treated it as a single, uniform process. This study is among the first to show, at the level of individual cells, that the trajectory differs significantly between sexes. The hope is that detailed maps like this one will eventually guide targeted interventions: the right treatment, at the right time, for the right person.